Kitty Yale
Company: Akero Therapeutics
Job title: Chief Development Officer
Seminars:
Evolving Innovative Trial Design with Diverse Patient Populations to Optimize Clinical Development 11:00 am
Designing a robust development program to accelerate drug development F1, F2, F3, F4: navigating diverse patient populations in clinical studies to optimize treatment Evaluating clinical development of EFX in Phase IIb and histological outcomesRead more
day: Day 2 Stream 2 AM